Dianthus Therapeutics, Inc. · NASDAQ:DNTH

Octagon Capital Advisors LP's stake in Dianthus Therapeutics, Inc. fell to 3.60% (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 14, 2026

Octagon Capital Advisors LP's stake in Dianthus Therapeutics, Inc. fell to 3.60%, 1,946,667 shares, as a passive investor on Mar 31, 2026. Filed May 14, 2026 (Schedule 13G/A).

Stake
3.60%
Shares
1,946,667
Intent
Passive
What changed
Fell below 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Octagon Capital Advisors LP3.60%1,946,667
Octagon Investments Master Fund LP3.00%1,655,000
Octagon Biotech Opportunities Fund I LP0.60%291,667
Ting Jia3.60%1,946,667

Source

View original at SEC

Related